JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B1564 Ranitidine

Target: Histamine H2 Receptors

Summary: Histamine H2-receptor antagonist

≥17.54 mg/mL
B1545 Brompheniramine hydrogen maleate

Summary: Histamine H1 receptors antagonist
B1565 Roxatidine Acetate HCl

Summary: Specific and competitive histamin H2-receptor antagonist

≥113.4 mg/mL
B1576 Olopatadine HCl

Summary: Histamine blocker

≥18.69 mg/mL
B1568 Azelastine HCl

Target: Histamine H1 Receptors

Summary: Potent, second-generation, selective, histamine receptor antagonist

≥20.92 mg/mL
B1560 Famotidine

Summary: Histamine H2-receptor antagonist

insoluble in H2O; insoluble in EtOH; ≥16.87 mg/mL
A3298 Cetirizine

Summary: Antihistamine

insoluble in EtOH; ≥122 mg/mL
A3315 Clemizole

Summary: H1 histamine receptor antagonist

insoluble in H2O; ≥16.2 mg/mL
A3727 Pitolisant hydrochloride

Summary: Nonimidazole inverse agonist

≥16.6 mg/mL
B6357 Nα-Methylhistamine dihydrochloride

Summary: histamine H3 receptor agonist

<19.81 mg/mL